Part: 12         Session: 145678910111213141516171819202122         Page 931932933934935936937938939940941942943944945946947948949950951952953954955956957958959960961962963964965966967968969970971972973974975976977978979980981982983984985986987988989990991992993994995996997998999 of 999

That's terrible. At Houston. He's the head of a very large medical school. (pause)

Baylor University.

Now, Mrs. Brewer says that in connection with the forthcoming meeting of the American Cancer Society in September, where you're going to be in attendance, when they talk about the. . .

You mean the meeting on vaccine?

Yes, the feasibility of developing a vaccine.

That's what we're going to discuss at the meeting -- the feasibility. Some biologists will say, “Of course it's feasible.” Other people will say, “You can't do it, from here” or something or other. If you get some of them worked up about the importance of it. . . Now we would save over 150,000 lives a year. I can't help but think that some people won't have some ingenious ideas about how to develop a practical vaccine. Don't you think?

Yes. And your foundation will have the Statistics.

Oh, we have all the statistics.

To present to them.

Oh, yes.